Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 30,000 | reported | 11 Aug 2025 | tx 2+30,000−30,000 |
| Bausch Health Companies Inc. | 20,756 | reported | 19 Aug 2019 | tx 7+59,511−15,596 |
| NewAmsterdam Pharma Co N.V. | 15,300 | reported | 07 Jan 2026 | tx 5+130,660 |
| Apogee Therapeutics, Inc. | 14,461 | reported | 17 Jun 2025 | tx 6+194,831 |
| Spyre Therapeutics, Inc. |
| 8,026 |
| reported |
| 27 May 2026 |
| tx 3+73,026 |
| Prometheus Biosciences, Inc. | 0 | reported | 16 Jun 2023 | tx 40+965,613−2,593,476 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 8,026 | 0.00 USD | deriv |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 3,400 | — | |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 15,300 | 0.00 USD | deriv |
| 11 Aug 2025 | EXERCISE | BridgeBio Oncology Therapeutics, Inc. | 30,000 | — | |
| 11 Aug 2025 | EXERCISE | BridgeBio Oncology Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Apogee Therapeutics, Inc. | 14,461 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 07 Jan 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 6,960 | — | |
| 06 Jan 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 32,500 | 0.00 USD | deriv |
| 12 Dec 2024 | PURCHASE | Apogee Therapeutics, Inc. | 12,500 | 49.85 USD | |
| 12 Dec 2024 | PURCHASE | Apogee Therapeutics, Inc. | 7,500 | 49.02 USD | |
| 17 Jul 2024 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 72,500 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Apogee Therapeutics, Inc. | 10,370 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Spyre Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 17 Aug 2023 | GRANT_AWARD | Apogee Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 17 Aug 2023 | GRANT_AWARD | Apogee Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 178,098 | — | |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 566,307 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 481,725 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 20,000 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 161,105 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 128,930 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 132,741 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 290,000 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 246,639 | — | deriv |